SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-016500
Filing Date
2022-07-05
Accepted
2022-07-05 07:05:30
Documents
17
Period of Report
2022-07-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arav20220630_8k.htm   iXBRL 8-K 35846
2 EXHIBIT 10.1 ex_391901.htm EX-10.1 75002
3 EXHIBIT 99.1 ex_391902.htm EX-99.1 12815
8 aravive01.jpg GRAPHIC 2621
9 aravive02.jpg GRAPHIC 5050
  Complete submission text file 0001437749-22-016500.txt   296576

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA arav-20220701.xsd EX-101.SCH 3600
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20220701_def.xml EX-101.DEF 11918
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20220701_lab.xml EX-101.LAB 15965
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20220701_pre.xml EX-101.PRE 12129
11 EXTRACTED XBRL INSTANCE DOCUMENT arav20220630_8k_htm.xml XML 2655
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 221063184
SIC: 2834 Pharmaceutical Preparations